Literature DB >> 16041799

Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase-2 via CD 40: relevance to Parkinson's disease.

Tatsusada Okuno1, Yuji Nakatsuji, Atsushi Kumanogoh, Masayuki Moriya, Hiroshi Ichinose, Hisae Sumi, Harutoshi Fujimura, Hitoshi Kikutani, Saburo Sakoda.   

Abstract

A glial reaction associated with up-regulation of inflammatory molecules has been suggested to play an important role in dopaminergic neuron loss in Parkinson's disease (PD). Among inflammatory molecules, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) have been focused upon as key factors in the pathogenesis. However, the mechanism of how these molecules are induced in PD brains is not clearly understood. We focused on CD 40, which is expressed on neural cells and could be implicated in the neuroinflammation by inducing inflammatory molecules. We showed that both iNOS and COX-2 were up-regulated in microglia and astrocytes by CD 40 stimulation in association with a low dose of interferon-gamma (IFN-gamma) in vitro. Selective loss of dopaminergic neurons was induced by costimulation with CD 40 and IFN-gamma in mesencephalic cultures, which was protected by selective inhibitors of iNOS and/or COX-2. We also found in CD 40-stimulated astrocytes an increase of a low-affinity IgE receptor CD 23, which is known to induce iNOS expression. Together these data suggest that up-regulated iNOS and COX-2 via the CD 40 pathway may lead to dopaminergic neuron loss and may participate in the neuroinflammaory pathway of PD. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041799     DOI: 10.1002/jnr.20599

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

1.  Involvement of nitric oxide in maneb- and paraquat-induced Parkinson's disease phenotype in mouse: is there any link with lipid peroxidation?

Authors:  Satya Prakash Gupta; Suman Patel; Sharawan Yadav; Anand Kumar Singh; Seema Singh; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

2.  The Effects of Crocin on 6-OHDA-Induced Oxidative/Nitrosative Damage and Motor Behaviour in Hemiparkinsonian Rats.

Authors:  Maryam Hosseini; Ziba Rajaei; Hojjatallah Alaei; Mohamadhasan Tajadini
Journal:  Malays J Med Sci       Date:  2016-12-07

3.  Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease.

Authors:  Min Li; Fu-rong Dai; Xiao-ping Du; Qi-dong Yang; Yuxiang Chen
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

Review 4.  CD40-CD40L in Neurological Disease.

Authors:  Heather D Ots; Jovanna A Tracz; Katherine E Vinokuroff; Alberto E Musto
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

5.  Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.

Authors:  Francisco Arnaldo Viana Lima; Ivan Pinheiro Joventino; Francisca Pinheiro Joventino; Aline Cordeiro de Almeida; Kelly Rose Tavares Neves; Marta Regina do Carmo; Luzia Kalyne Almeida Moreira Leal; Geanne Matos de Andrade; Glauce Socorro de Barros Viana
Journal:  Neurochem Res       Date:  2017-08-31       Impact factor: 3.996

6.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

7.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

Review 8.  Organ systems dependent on nitric oxide and the potential for nitric oxide-targeted therapies in related diseases.

Authors:  Norman K Hollenberg
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

9.  BAFF controls neural cell survival through BAFF receptor.

Authors:  Satoru Tada; Teruhito Yasui; Yuji Nakatsuji; Tatsusada Okuno; Toru Koda; Hideki Mochizuki; Saburo Sakoda; Hitoshi Kikutani
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt.

Authors:  Bin Xing; Tao Xin; Randy Lee Hunter; Guoying Bing
Journal:  J Neuroinflammation       Date:  2008-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.